Myogem Health Company S.L. is a spanish healthcare company located in Mollet del Vallés, Barcelona, SPAIN.
The company is a Spin-off of Inkemia IUCT Group, that focuses its attention on R&D and commercialization of new products against Rare Diseases.
Rare diseases have always been treated in a quite different way respect to the rest of the illness, because of the narrow range of company disposed to invest on them and the little attention they receive from the media, the intent of Myogem Health Company is offering to the patients affected by these disease a possibility to have better life through a range of products that aim to improve their health condition and quality of their lives.
Everything started back in 2007 when Inkemia IUCT Group first started its research in Myotonic Dystrophy with a project called “New therapeutic Approaches for myotonic dystrophy: functional genomics and in vivo drug discovery studies”, a Cetegen Project, funded by the Genome Spain Foundation, during which no exploitable results were obtained.
The next project happened in 2009, thanks to the participation in a project called “La Marató de TV3“. That edition that was particularly focused on fundraising for projects for the discovering of new treatments against rare diseases.